Nobuyuki Katakami

819 total citations
26 papers, 621 citations indexed

About

Nobuyuki Katakami is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Nobuyuki Katakami has authored 26 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Nobuyuki Katakami's work include Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Nobuyuki Katakami is often cited by papers focused on Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Nobuyuki Katakami collaborates with scholars based in Japan, United States and Norway. Nobuyuki Katakami's co-authors include Katsuhiro Masago, Shiro Fujita, Yasushi Yatabe, Reiko Kaji, Akito Hata, Jumpei Takeshita, Ryoji Kato, Yukihiro Imai, Akito Hata and Chiyuki Okuda and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Nobuyuki Katakami

24 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuyuki Katakami Japan 12 485 315 133 133 59 26 621
Katherine A. Scilla United States 11 290 0.6× 363 1.2× 136 1.0× 162 1.2× 44 0.7× 25 583
J.M. Sánchez-Torres Spain 13 428 0.9× 614 1.9× 150 1.1× 104 0.8× 39 0.7× 21 772
Eisaku Miyauchi Japan 13 344 0.7× 355 1.1× 239 1.8× 235 1.8× 52 0.9× 66 691
Ramón Palmero Spain 14 328 0.7× 384 1.2× 159 1.2× 79 0.6× 41 0.7× 50 646
Shinichiro Shimamatsu Japan 12 277 0.6× 352 1.1× 175 1.3× 89 0.7× 29 0.5× 40 580
Ji Zhou China 16 174 0.4× 292 0.9× 129 1.0× 91 0.7× 131 2.2× 39 621
Dov Flex Israel 15 316 0.7× 369 1.2× 104 0.8× 91 0.7× 39 0.7× 28 663
Nicolas Piton France 14 310 0.6× 184 0.6× 98 0.7× 116 0.9× 20 0.3× 43 539
Maria Bassanelli Italy 10 326 0.7× 419 1.3× 99 0.7× 68 0.5× 33 0.6× 23 547
Jumpei Kashima Japan 13 311 0.6× 233 0.7× 78 0.6× 53 0.4× 76 1.3× 41 566

Countries citing papers authored by Nobuyuki Katakami

Since Specialization
Citations

This map shows the geographic impact of Nobuyuki Katakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuyuki Katakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuyuki Katakami more than expected).

Fields of papers citing papers by Nobuyuki Katakami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuyuki Katakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuyuki Katakami. The network helps show where Nobuyuki Katakami may publish in the future.

Co-authorship network of co-authors of Nobuyuki Katakami

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuyuki Katakami. A scholar is included among the top collaborators of Nobuyuki Katakami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuyuki Katakami. Nobuyuki Katakami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Masago, Katsuhiro, Kei Irie, Shiro Fujita, et al.. (2018). Relationship between Paronychia and Drug Concentrations of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. Oncology. 95(4). 251–256. 9 indexed citations
2.
3.
Masago, Katsuhiro, Shiro Fujita, Akito Hata, et al.. (2018). Validation of the digital PCR system in tyrosine kinase inhibitor‐resistant EGFR mutant non‐small‐cell lung cancer. Pathology International. 68(3). 167–173. 6 indexed citations
4.
Sakai, Nobuyuki, Mikiya Beppu, Chiaki Sakai, et al.. (2018). Quantitative Analysis of Conebeam CT for Delineating Stents in Stent-Assisted Coil Embolization. American Journal of Neuroradiology. 39(3). 488–493. 8 indexed citations
5.
Sakai, Nobuyuki, Mikiya Beppu, Chiaki Sakai, et al.. (2017). Optimal dilution of contrast medium for quantitating parenchymal blood volume using a flat-panel detector. Journal of International Medical Research. 46(1). 464–474. 5 indexed citations
6.
Hata, Akito, Nobuyuki Katakami, Shigeki Nanjo, et al.. (2017). Programmed death-ligand 1 expression and T790M status in EGFR -mutant non-small cell lung cancer. Lung Cancer. 111. 182–189. 33 indexed citations
7.
Masago, Katsuhiro, et al.. (2017). Computed tomography‑guided lung biopsy: Association between biopsy needle angle and pneumothorax development. Molecular and Clinical Oncology. 8(2). 336–341. 23 indexed citations
8.
Hata, Akito, Nobuyuki Katakami, Shigeki Nanjo, et al.. (2016). Correlation between programmed death-ligand 1 (PD-L1) expression and T790M status in EGFR-mutant non-small cell lung cancer (NSCLC). Annals of Oncology. 27. vi428–vi428. 1 indexed citations
9.
Sakai, Nobuyuki, Mikiya Beppu, Chiaki Sakai, et al.. (2016). Dose reduction in cone-beam CT scanning for intracranial stent deployment before coil embolization of intracranial wide-neck aneurysms. Interventional Neuroradiology. 22(4). 420–425. 5 indexed citations
10.
Fujita, Shiro, Katsuhiro Masago, Nobuyuki Katakami, & Yasushi Yatabe. (2016). Transformation to SCLC after Treatment with the ALK Inhibitor Alectinib. Journal of Thoracic Oncology. 11(6). e67–e72. 106 indexed citations
11.
Otsuka, Kyoko, Akito Hata, Jumpei Takeshita, et al.. (2015). EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer. Cancer Chemotherapy and Pharmacology. 76(4). 835–841. 39 indexed citations
12.
Fujita, Shiro, Katsuhiro Masago, Jumpei Takeshita, et al.. (2015). Validation of an Ion Torrent Sequencing Platform for the Detection of Gene Mutations in Biopsy Specimens from Patients with Non-Small-Cell Lung Cancer. PLoS ONE. 10(6). e0130219–e0130219. 6 indexed citations
13.
Masago, Katsuhiro, Shiro Fujita, Miho Muraki, et al.. (2015). Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations. BMC Cancer. 15(1). 908–908. 27 indexed citations
14.
Hata, Akito, Nobuyuki Katakami, Hiroshige Yoshioka, et al.. (2015). Spatiotemporal T790M Heterogeneity in Individual Patients with EGFR-Mutant Non–Small-Cell Lung Cancer after Acquired Resistance to EGFR-TKI. Journal of Thoracic Oncology. 10(11). 1553–1559. 122 indexed citations
15.
Takeshita, Jumpei, Katsuhiro Masago, Ryoji Kato, et al.. (2015). A new strategy for metachronous primary lung cancer: stereotactic body radiation therapy with concurrent chemotherapy.. PubMed. 35(5). 3103–7. 5 indexed citations
16.
Shintani, Takashi, Katsuhiro Masago, Kenji Takayama, et al.. (2014). Stereotactic Body Radiotherapy for Synchronous Primary Lung Cancer: Clinical Outcome of 18 Cases. Clinical Lung Cancer. 16(5). e91–e96. 22 indexed citations
17.
Hata, Akito, Nobuyuki Katakami, Hiroshige Yoshioka, et al.. (2014). Spatiotemporal T790M heterogeneity in individual patients with non-small cell lung cancer (NSCLC) after acquired resistance to EGFR-tyrosine kinase inhibitor (TKI).. Journal of Clinical Oncology. 32(15_suppl). 8067–8067. 2 indexed citations
18.
Hata, Akito, Shiro Fujita, Nobuyuki Katakami, Chiaki Sakai, & Yukihiro Imai. (2010). Bilateral Subdural Hematoma Associated with Central Nervous System Metastases from Lung Cancer. Journal of Thoracic Oncology. 6(1). 207–208.
19.
20.
Masago, Katsuhiro, Ryo Asato, Shiro Fujita, et al.. (2008). Epidermal growth factor receptor gene mutations in papillary thyroid carcinoma. International Journal of Cancer. 124(11). 2744–2749. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katherine A. Scilla Breakdown of academic impact, for papers by J.M. Sánchez-Torres Breakdown of academic impact, for papers by Eisaku Miyauchi Breakdown of academic impact, for papers by Ramón Palmero Breakdown of academic impact, for papers by Shinichiro Shimamatsu Breakdown of academic impact, for papers by Ji Zhou Breakdown of academic impact, for papers by Dov Flex Breakdown of academic impact, for papers by Nicolas Piton Breakdown of academic impact, for papers by Maria Bassanelli Breakdown of academic impact, for papers by Jumpei Kashima
Rankless by CCL
2026